Home   >  
Protease/Metabolic Enzyme
  • Neuro Signaling Pathway
  >  
FAAH

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

FAAH

Chemical Structure Cat. No. Product Name CAS No.
JZL195 Chemical Structure
BCP23894 JZL195 1210004-12-8
JZL195 is a selective and efficacious dual FAAH/MAGL inhibitor with IC50 of 13 nM and 19 nM for mouse brain FAAH and MAGL respectively.
BIA10-2474 Chemical Structure
BCP29970 BIA10-2474 1233855-46-3
BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.
JNJ1661010 Chemical Structure
BCP06935 JNJ1661010 681136-29-8
JNJ-1661010 is a potent and selective FAAH inhibitor with IC50 of 10 nM (rat) and 12 nM (human), exhibits >100-fold selectivity for FAAH-1 when compared to FAAH-2.
ArachidonylethanolaMide Chemical Structure
BCP16072 ArachidonylethanolaMide 94421-68-8
It is degraded primarily by the fatty acid amide hydrolase (FAAH) enzyme, which converts anandamid.
JNJ42165279 Chemical Structure
BCP16594 JNJ42165279 1346528-50-4
JNJ-42165279 is a FAAH inhibitor with IC50 of 70 ± 8 nM and 313 ± 28 nM for hFAAH and rFAAH, respectively.
URB597 Chemical Structure
BCP27727 URB597 546141-08-6
URB597 is a potent, orally bioavailable FAAH inhibitor with IC50 of 4.6 nM, with no activity on other cannabinoid-related targets.
PF3845 Chemical Structure
BCP02317 PF3845 1196109-52-0
PF-3845 (PF 3845) is a selective fatty acid amide hydrolase (FAAH) inhibitor (Ki = 0.23 μM).
PF-04457845 Chemical Structure
BCP05805 PF-04457845 1020315-31-4
PF-04457845 is a potent and exquisitely selective inhibitor of FAAH, with an IC50 of 7.2 nM, and both analgesic and antiinflammatory effects in animal studies comparable to naproxen.
0086-13720134139